Notice of Application - 2010
[Federal Register: December 3, 2010 (Volume 75, Number 232)]
[Notices]
[Page 75498]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr03de10-80]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on July 8, 2010, Agilent
Technologies, 25200 Commercentre Drive, Lake Forest, California 92630-
8810, made application by letter to the Drug Enforcement Administration
(DEA) to be registered as a bulk manufacturer of the basic classes of
controlled substances listed in schedule II:
| Drug |
Schedule |
| Phencyclidine (7471) |
II |
1-piperidinocyclohex-
anecarbonitrile (8603) |
II |
| Benzoylecgonine (9180) |
II |
The company plans to manufacture small quantities of the listed
controlled substances for use in diagnostic products.
Agilent Technologies submitted this application because, effective
May 14, 2010, Varian, Inc., located at 25200 Commercentre Drive, Lake
Forest, California 92630-8810, became a wholly-owned subsidiary of
Agilent Technologies. Varian, Inc.'s legal existence as a corporation
and as a DEA registrant as a bulk manufacturer will eventually cease
and Agilent Technologies will take over all of Varian Inc.'s activities
with regard to controlled substances, requiring possession of a DEA
registration as a bulk manufacturer issued to Agilent Technologies.
Presently, Agilent Technologies' activities with regard to controlled
substances will be exactly the same as performed by Varian, Inc.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR Sec. 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than February 1, 2011.
Dated: November 18, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-30358 Filed 12-2-10; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |